Expression of the murine leukemia virus protease in fusion with maltose-binding protein in Escherichia coli

Protein Expression and Purification

Volumn 35, Issue 1, 2004, Pages 62-68

  Fehér, Anita ^a   Boross, Péter ^a   Sperka, Tamás ^a   Oroszlan, Stephen ^b   Tözsér, József ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

MLV; Purification; Retroviral protease

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MURINAE; MURINE LEUKEMIA VIRUS;

EID: 15244360113     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2004.01.008     Document Type: Article

References (31)

1. S. Oroszlan, R.B. Luftig, Retroviral proteinases, Curr. Top. Microbiol. Immunol. 157 (1990) 153-185.
2. R. Swanstrom, J. Eron, Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance, Pharmacol. Ther. 86 (2000) 145-170.
3. Y. Yoshinaka, I. Katoh, T.D. Copeland, S. Oroszlan, Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon, Proc. Natl. Acad. Sci. USA 82 (1985) 1618-1622.
4. C.E. Thomas, A. Ehrhardt, M.A. Kay, Progress and problems with the use of viral vectors for gene therapy, Nat. Rev. Genet. 4 (2003) 346-358.
5. L. Menendez-Arias, J. Tözsér, S. Oroszlan, Moloney murine leukemia virus retropepsin, in: A.J. Barrett, N. Rawlings, J. Woessner (Eds.), Handbook of Proteolytic Enzymes, second ed., Elsevier Science Ltd., 2004 (in press).
6. L. Menendez-Arias, D. Gotte, S. Oroszlan, Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme, Virology 196 (1993) 557-563.
7. L. Menendez-Arias, I.T. Weber, J. Soss, R.W. Harrison, D. Gotte, S. Oroszlan, Kinetic and modeling studies of subsites S4-S3′ of Moloney murine leukemia virus protease, J. Biol. Chem. 269 (1994) 16795-16801.
8. K. Cannon, L. Qin, G. Schumann, J.D. Boeke, Moloney murine leukemia virus protease expressed in bacteria is enzymatically active, Arch. Virol. 143 (1998) 381-388.
9. L. Menendez-Arias, I.T. Weber, S. Oroszlan, Mutational analysis of the substrate binding pocket of murine leukemia virus protease and comparison with human immunodeficiency virus proteases, J. Biol. Chem. 270 (1995) 29162-29168.
10. P.L. Black, M.B. Downs, M.G. Lewis, M.A. Ussery, G.B. Dreyer, S.R. Petteway Jr., D.M. Lambert, Antiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue culture, Antimicrob. Agents Chemother. 37 (1993) 71-77.
11. D.R. Davies, The structure and function of the aspartic proteinases, Annu. Rev. Biophys. Biophys. Chem. 19 (1990) 189-215.
12. Y.S. Cheng, F.H. Yin, S. Foundling, D. Blomstrom, C.A. Kettner, Stability and activity of human immunodeficiency virus protease: comparison of the natural dimer with a homologous, single-chain tethered dimer, Proc. Natl. Acad. Sci. USA 87 (1990) 9660-9664.
13. C.L. DiIanni, L.J. Davis, M.K. Holloway, W.K. Herber, P.L. Darke, N.E. Kohl, R.A. Dixon, Characterization of an active single polypeptide form of the human immunodeficiency virus type 1 protease, J. Biol. Chem. 265 (1990) 17348-17354.
14. L.M. Babe, J. Rose, C.S. Craik, Synthetic interface peptides alter dimeric assembly of the HIV 1 and 2 proteases. Protein Sci. 1 (1992) 1244-1253.
15. J. Tözsér, F.H. Yin, Y.S. Cheng, P. Bagossi, I.T. Weber, R.W. Harrison, S. Oroszlan, Activity of tethered human immunodefi-ciency virus 1 protease containing mutations in the flap region of one subunit, Eur. J. Biochem. 244 (1997) 235-241.
16. P. Bagossi, Y.S. Cheng, S. Oroszlan, J. Tözsér, Comparison of the specificity of homo-and heterodimeric linked HIV-1 and HIV-2 proteinase dimers, Protein Eng. 11 (1998) 439-445.
17. R.J. Gorelick, L.E. Henderson, J.P. Hanser, A. Rein, Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence, Proc. Natl. Acad. Sci. USA 85 (1988) 8420-8424.
18. L. Menendez-Arias, M. Young, S. Oroszlan, Purification and characterization of the mouse mammary tumor virus protease expressed in Escherichia coli, J. Biol. Chem. 267 (1992) 24134-24139.
19. J. Sambrook, D.W. Russell, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2001.
20. J. Tözsér, I. Bláha, T.D. Copeland, E.M. Wondrak, S. Oroszlan, Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins, FEBS Lett. 281 (1991) 77-80.
21. H. Towbin, T. Staehelin, J. Gordon, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc. Natl. Acad. Sci. USA 76 (1979) 4350-4354.
22. J.M. Louis, R.A. McDonald, N.T. Nashed, E.M. Wondrak, D.M. Jerina, S. Oroszlan, P.T. Mora, Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli, Eur. J. Biochem. 199 (1991) 361-369.
23. G. Fenyofalvi, P. Bagossi, T.D. Copeland, S. Oroszlan, P. Boross, J. Tözsér, Expression and characterization of human foamy virus proteinase, FEBS Lett. 462 (1999) 397-401.
24. G. Zahuczky, P. Boross, P. Bagossi, G. Emri, T.D. Copeland, S. Oroszlan, J.M. Louis, J. Tözsér, Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase, Biochem. Biophys. Acta 1478 (2000) 1-8.
25. R.B. Kapust, D.S. Waugh, Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused, Protein Sci. 8 (1999) 1668-1674.
26. C. Wang, A.F. Castro, D.M. Wilkes, G.A. Altenberg, Expression and purification of the first nucleotide-binding domain and linker region of human multidrug resistance gene product: comparison of fusions to glutathione S-transferase, thioredoxin and maltose-binding protein, Biochem. J. 338 (1999) 77-81.
27. H.G. Krausslich, Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity, Proc. Natl. Acad. Sci. USA 88 (1991) 3213-3217.
28. R.J. Jenny, K.G. Mann, R.L. Lundblad, A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa, Protein Expr. Purif. 31 (2003) 1-11.
29. 6-tag and maltose-binding protein double-affinity fusion system, Protein Expr. Purif. 10 (1997) 309-319.
30. J.F. Kane, Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli, Curr. Opin. Biotechnol. 6 (1995) 494-500.
31. R.B. Kapust, K.M. Routzahn, D.S. Waugh, Processive degradation of nascent polypeptides, triggered by tandem AGA codons, limits the accumulation of recombinant tobacco etch virus protease in Escherichia coli BL21(DE3), Protein Expr. Purif. 24 (2002) 61-70.